a

Facebook

Twitter

© Copyright 2023 COFFYLAW, LLC.
All Rights Reserved.

9:00 AM - 6:00 PM

Our Opening Hours Mon. - Fri.

Call Us For Free Consultation

Facebook

Twitter

LinkedIn

Search
Menu
 

March 2020

COFFYLAW, LLC > 2020 > March

Other Barks & Bites for Friday, March 13: Federal Circuit, Copyright Office, Ninth Circuit Brace for Coronavirus Concerns; Huawei Tops EU Patent Applicants; Apple Pays VirnetX

Bites (noun): more meaty news to sink your teeth into. Barks (noun): peripheral noise worth your attention. This week in Other Barks & Bites: Fears over coronavirus tank stocks on Wall Street and trigger changes at the Federal Circuit, the closure of the Library of Congress and the U.S. Copyright Office, as well as move the location of oral arguments in the Ninth Circuit; Apple pays VirnetX after decade-long battle; INTA has had to reschedule its Annual Meeting for November and combine it with the Association’s Leadership Meeting due to the coronavirus; the Senate IP Subcommittee looks at the applicability of the European Union...

Continue reading

EPO Applications Up 4%, Led by Digital Communication and Computer Technology, 5.5% Rise in U.S. Applicants

“U.S. entities also featured prominently in medical technology, accounting for 40% of all patent applications in this sector, pharmaceuticals and biotechnology.” Patent applications filed at the European Patent Office (EPO) rose 4% to 181,406 in 2019, driven by substantial increases from Chinese, Korean and U.S. applicants, according to a report published by the Office yesterday. The United States was the number one country of residence of applicants, with 46,201 applications—a rise of 5.5%. This accounted for 25% of all European patent applications. The U.S. was followed by Germany and Japan. Applications from the People’s Republic of China increased by 29.2% to 12,247 putting the country in...

Continue reading

Chrimar Asks Supreme Court to Decide Whether PTAB Can Reverse Final Article III Judgments

“The time has come to harmonize the Federal Circuit with Supreme Court precedent and the Restatement, unsplit the circuits, restore constitutional validity to our system of parallel track patentability litigation, and eliminate the waste and gamesmanship that current precedent incentivizes.” Earlier this week, Chrimar Systems, Inc. filed a petition for certiorari asking the U.S. Supreme Court to take up a case on appeal from the U.S. Court of Appeals for the Federal Circuit. Chrimar is asking the nation’s highest court to answer the question of whether the Federal Circuit may: 1. apply a finality standard for patent cases that conflicts with the standard...

Continue reading

Trademark Modernization Act Would Restore Presumption of Irreparable Harm in Trademark Cases

“The Act clarifies that for trademark violations, a rebuttable presumption of irreparable harm exists given the consumer protection concerns that would occur otherwise.” Senators Thom Tillis (R-NC) and Chris Coons (D-DE) and Representatives Hank Johnson (D-GA), Doug Collins (R-GA), Martha Roby (R-AL) and Jerry Nadler (D-NY) yesterday introduced legislation to modernize the U.S. trademark system. The Trademark Modernization Act of 2020 is in part a response to the surge in fraudulent trademark filings, largely originating from China, that both the U.S. Patent and Trademark Office (USPTO) and Congress have been grappling with over the last year. Perhaps most notably, in a stated effort to...

Continue reading

Mad Dash to Coronavirus Vaccine May Face Legal Hurdles

“Under the Bayh-Dole Act of 1980, the government can retain ownership rights in some patents for inventions generated by government-funded research…. The particular intellectual property issues raised by the new coronavirus vaccine vary wildly by who, and in what circumstances, the vaccine is developed.” Almost a third of the recently signed $8.3 billion bill to fund the United States response to the coronavirus outbreak is devoted directly to vaccine research and development. And while the realities of drug development and FDA approval mean it is unlikely any vaccine will be available before next year, the government has numerous tools at its...

Continue reading

An Inventor’s Guide to Enforcing Patents on a Budget

“Just because lawyers agree to take your case on contingency does not mean that litigating and enforcing patents costs you nothing out of pocket. There are other litigation expenses that must be accounted for, and it is usually your responsibility to pay for those up front.” Patent litigation and enforcing patents can be cost prohibitive for many individual inventors and smaller businesses. Hourly rates at large firms may be out of reach for those with “not so deep pockets,” and most litigation funding companies either avoid patent litigation altogether or require a case valuation in the tens of millions of dollars....

Continue reading

Patent Filings Roundup: Supercell Locked in Dispute with Gree, Vudu Fends off Uniloc, BASF PGRs Ingevity Patents

Every week, Unified Patents compiles all Patent Trial and Appeal Board (PTAB) and district court filings, lists them, and releases them daily to subscribers. Each Wednesday, IP Watchdog will post the list, with a handful of interesting cases highlighted with context. To see the docket, filings, and learn more about the case, click on the links provided below. Litigation financing or patent aggregator parent data is provided where known and confirmable. The results appear in chronological order, below. Given that filings were light this week (perhaps the Coronavirus or the cancellation of the PTAB Bar Association’s annual meeting are to blame),...

Continue reading

Senate IP Subcommittee Examines Foreign Approaches to Digital Piracy in Second Hearing on U.S. Copyright Reform

“We finance our projects by granting companies exclusive distribution rights,” Yunger said. “Why would any financial partner pay for movies that are widely offered for free online knowing full well that they may never recoup their investments?” – Jonathan Yunger, Millennium Films Senate IP Subcommittee Chair, Senator Thom Tillis (R-NC), yesterday led the second in a series of Subcommittee hearings addressing the possibility of updating the U.S. Digital Millennium Copyright Act (DMCA). The hearing, titled “Copyright Law in Foreign Jurisdictions: How are other countries handling digital piracy?”, was aimed at examining foreign copyright laws in order to consider what may or may not...

Continue reading

IPWatchdog CON2020 Has Been RESCHEDULED for September 13-15, 2020

We have great news to share with all of our readers and our IPWatchdog CON2020 Speakers, Sponsors, Exhibitors and registrants. We have finally worked out an amicable resolution with the Renaissance Dallas Richardson hotel. Although we will still hold a Virtual Program on Monday, March 16, IPWatchdog CON2020 is no longer canceled. We have rescheduled for Sunday, September 13 through Tuesday, September 15, 2020. The program will be nearly identical to the live program we had scheduled for this month. As we work out the details for the newly scheduled event, we will update the IPWatchdog CON2020 website with any changes that...

Continue reading

We Won’t Stop Coronavirus Without IP

“Any of the IP-robbing proposals on the policy table would weaken our nation’s biopharmaceutical sector, diminish IP exclusivity, deny Americans the innovations patients enjoy the earliest access to, and take away from our patent system, which has already endured repeated assaults by Congress, courts and administrative bodies for two decades.” The recent White House meeting with leaders from American pharmaceutical companies sought their help in solving the coronavirus that originated in Wuhan, China and is currently gripping the globe. The meeting was part of the U.S. government marshaling our nation’s private and public medical research and development (R&D) resources in a...

Continue reading